Drug class in one race
EGFR + HER3 drugs for Non-Small Cell Lung Cancer
5 tracked EGFR + HER3 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the EGFR + HER3 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
3 Phase 31 Phase 2/31 Phase 2